Logo
M

MyoKardia

30 employees

MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
drug development
heart failure
Genetic Heart Disease
Biopharma
biotechnology
Health Care
therapeutics
R&D
drug discovery
precision medicine
Therapeutics
cardiovascular disease
Cardiomyopathy
Medical

Date founded

2012

Funding rounds raised

Total raised

$46M

from 8 investors over 8 rounds

M

MyoKardia raised $46M on April 30, 2015

Investors: BridgeBio, Casdin Capital, LLC and Cowen Inc.

M

MyoKardia raised $10M on August 22, 2014

Investors: BridgeBio, Third Rock Ventures, Cowen Inc. and Casdin Capital, LLC

M

MyoKardia raised $38M on September 20, 2012

Investors: Third Rock Ventures

FAQ